Office of Regulatory Affairs, Arkansas Laboratory, U.S. Food and Drug Administration, 3900 NCTR Road, Jefferson, AR 72079, United States.
Office of Regulatory Affairs, Arkansas Laboratory, U.S. Food and Drug Administration, 3900 NCTR Road, Jefferson, AR 72079, United States.
J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Aug 1;1091:14-20. doi: 10.1016/j.jchromb.2018.05.028. Epub 2018 May 19.
Liposomes are used in commercial pharmaceutical formulations (PFs) and dietary supplements (DSs) as a carrier vehicle to protect the active ingredient from degradation and to increase the half-life of the injectable. Even as the commercialization of liposomal products has rapidly increased, characterization methodologies to evaluate physical and chemical properties of the liposomal products have not been well-established. Herein we develop rapid methodologies to evaluate chemical and selected physical properties of liposomal formulations. Chemical properties of liposomes are determined by their lipid composition. The lipid composition is evaluated by first screening of the lipids present in the sample using HPLC-ELSD followed by HPLC-MSMS analysis with high mass accuracy (<5 ppm), fragmentation pattern and lipid structure databases searching. Physical properties such as particle size and size distribution were investigated using Tunable Resistive Pulse Sensing (TRPS). The developed methods were used to analyze commercially available PFs and DSs. As results, PFs contain distinct number of lipids as indicated by the manufacture, but DSs were more complicated containing a large number of lipids belonging to different sub-classes. Commercially available liposomes have particles with wide size distribution based on size measurements performed by TRPS. The high mass accuracy as well as identification lipids using multiple fragment ions aided to accurately identify the lipids and differentiate them from other lipophilic molecules. The developed analytical methodologies were successfully adapted to measure the physiochemical properties of commercial liposomes.
脂质体被用于商业药物制剂(PFs)和膳食补充剂(DSs)中,作为载体来保护活性成分免受降解,并延长可注射制剂的半衰期。尽管脂质体产品的商业化迅速增长,但评估脂质体产品物理和化学性质的表征方法尚未得到很好的建立。在这里,我们开发了快速评估脂质体制剂化学和部分物理性质的方法。脂质体的化学性质取决于其脂质组成。脂质组成首先通过使用 HPLC-ELSD 对样品中存在的脂质进行初步筛选,然后使用具有高质量精度(<5 ppm)、碎片模式和脂质结构数据库搜索的 HPLC-MSMS 分析进行评估。使用可调电阻脉冲感应(TRPS)研究了物理性质,如粒径和粒径分布。所开发的方法用于分析市售的 PFs 和 DSs。结果表明,PFs 中含有制造商所指示的不同数量的脂质,但 DSs 则更为复杂,含有大量属于不同亚类的脂质。根据 TRPS 进行的粒径测量,市售脂质体的粒子具有较宽的粒径分布。高质量精度以及使用多个碎片离子鉴定脂质有助于准确鉴定脂质,并将其与其他亲脂性分子区分开来。所开发的分析方法成功地适用于测量商业脂质体的物理化学性质。